Trendy soft drink loved by millions could 'protect against bowel cancer' in some people, study reveals
Speaking of the findings on Instagram, Dr Kunal Sood, an anaesthesiologist from Maryland, USA, said: 'Even though the study was just for ulcerative colitis patients, it may be a gentle, food-based tool to support gut health with your doctor's guidance.'
Ulcerative colitis is a long-term condition where the colon and rectum become inflamed, causing ulcers to develop on the lining of the large intestine.
Now, experts believe that coconut water could help keep symptoms of the painful condition under control and reduce the risk of complications like bowel cancer.
Common symptoms of the condition—which affects around 300,000 people in the UK—include debilitating diarrhoea, severe abdominal pain, fatigue, and weight loss.
Symptoms can also worsen and affect other parts of the body causing fat to swell under the skin, painful joints and even weakened bones.
The researchers, from All India Institute of Medical Sciences, analysed 97 patients with mild to moderate ulcerative colitis to see whether coconut water would have anti-inflammatory effects on patients' gut microbiome.
They found that drinking 400ml of coconut water a day for eight weeks led to higher rates of clinical remission—where symptoms lessen to the point that they're almost gone—compared to a placebo.
In a video posted to Instagram, Dr Sood who was not involved in the study, added: 'Researchers also found that it shifted the gut microbiome, increasing beneficial bacteria while reducing inflammatory bacteria.
'Its high potassium content and anti-microbial peptides may play a role in that effect,' he added.
Most concerningly, patients with ulcerative colitis also have an increased risk of bowel cancer, with the risk becoming more severe the longer a patient has lived with the disease.
Living with the condition for 30 years can increase the risk of bowel cancer by 18 per cent, according to studies.
But now researchers say drinking just 400ml of coconut water daily could help manage symptoms and ward off the deadly disease.
Coconut water has surged in popularity in recent years for its supposed health benefits as a natural source of electrolytes, vitamins and minerals for as little as £2.20 a bottle.
The water is the clear substance found inside green, unripe coconuts and just one cup of it is said to contain an impressive 600mg of potassium.
According to the NHS, adults should aim for around 3,500mg of potassium a day.
This essential mineral helps keep fluid and sodium levels, reducing inflammation in the body.
Coconut water also contains high levels of antioxidants, which can help to neutralise oxidative stress which leads to cell damage.
Ulcerative colitis patients are at higher risk for developing bowel cancer because chronic inflammation can result in the continuous turnover of cells in the intestine.
This rapid turnover increases the chance of abnormalities that may lead to cancer.
In order to reduce the risk of the condition developing into bowel cancer, patients are currently recommended under NHS guidelines to eat a balanced diet, including plenty of fresh fruit and vegetables—like coconut water.
Unfortunately, many patients are often unaware that their condition has developed into bowel cancer as the initial symptoms of the disease are similar.
These include blood in the stool, diarrhoea and abdominal pain—all of which are common symptoms for ulcerative colitis patients.
To try and catch the disease early, patients with ulcerative colitis are invited for regular check-ups to look for signs of bowel cancer from 10 years after their first symptoms develop.
This involves examining the bowel with a camera inserted into the rectum—known as a colonoscopy.
The findings come amid a surge in bowel cancer cases in young people—many of whom are perfectly fit and healthy.
While research is yet to identify a specific smoking gun, groups of scientists have posed a variety of theories, including rising obesity levels, poor diets and microplastic pollution.
Common symptoms of the disease include needing to go to the toilet with more urgency, rectal bleeding, blood in the stool—which may appear red or black in colour—and change in consistency.
Some patients may also experience abdominal pain, bloating and unexplained weight loss.
Overall, just over half of bowel cancer patients are expected to be alive ten years after their diagnosis, with 90 per cent of people diagnosed at stage 1 surviving for at least five years.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
Texas Governor refuses to release ‘intimate' emails between him and Musk
Texas Governor Greg Abbott is refusing to release emails exchanged with billionaire Elon Musk, citing their "intimate and embarrassing" nature and lack of public interest. The Texas Newsroom, in collaboration with ProPublica and The Texas Tribune, requested the emails to investigate Musk's influence in the state. Abbott's office initially charged a fee for collating the emails but later declared them confidential after the payment was processed. Elon Musk's lawyer, representing SpaceX, also argued against their release, claiming they contain commercially sensitive information that could harm the company. The decision on whether to release the emails now rests with Texas Attorney General Ken Paxton, who has yet to issue a ruling.
Medical News Today
an hour ago
- Medical News Today
Slowing aging: Psilocybin helps extend life span in human cells by over 50%
Psilocybin is a chemical that is found in a wide variety of mushrooms known for their euphoric and hallucinogenic effects. Over the past few years, there have been a number of studies investigating the use of psilocybin for the treatment of mental health disorders and medical conditions. A new study says psilocybin may help delay aging by increasing the cellular life span of human skin and lung cells by more than 50%. Scientists also reported evidence psilocybin may help protect the body from age-related diseases through several health-protecting qualities, via a mouse is a chemical that is found in a wide variety of mushrooms. Also known as 'shrooms' and 'magic mushrooms,' psilocybin is known for its euphoric and hallucinogenic effects. Over the past few years, there have been a number of studies investigating the use of psilocybin for the treatment of mental health disorders such as treatment-resistant depression, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and substance use disorders, as well as medical conditions like migraine, Alzheimer's disease, irritable bowel syndrome (IBS), and Parkinson's disease. 'The overwhelming majority of what we know about psilocybin is from clinical outcomes (with >150 clinical trials ongoing or completed) and impacts on the brain,' Louise Hecker, PhD, associate professor at Baylor College of Medicine, told Medical News Today. 'Psilocybin is well known for its hallucinogenic properties. However, we know very little about what it does otherwise, particularly its impact systemically on the rest of the body.'Hecker is the senior author of a new study recently published in the journal npj Aging that has found indication that psilocybin may help delay aging by increasing the cellular lifespan of human skin and lung cells by more than 50%. Scientists also reported evidence psilocybin may help protect the body from age-related diseases, such as neurodegeneration, heart disease, and cancer through several health-protecting qualities, via a mouse helps extend life in cells by over 50%For this study, researchers first used a cellular aging model of human lung cells to see how psilocin — the active ingredient in mushrooms that causes hallucinogenic effects — would impact them. Scientists reported that psilocin helped to extend the cellular lifespan of human skin and lung cells by more than 50%.'The significance is that psilocin-treated cells do age, however they age at a slower rate, while maintaining the properties of 'young' cells longer,' Hecker, who was an associate professor at Emory University at the time of the study, said. When moving to a mouse model, Hecker and her team also discovered that mice at the equivalent of 60-65 human years given psilocybin lived longer than those who did not receive it. Additionally, these mice displayed healthier features, such as fewer white hairs and hair regrowth.'We designed this experiment with the clinical relevance in mind — wouldn't it be great if we could give an intervention to elderly adults that helps them to live healthier longer?,' Hecker explained. 'Our study suggests that this is possible.'Psilocybin helps maintain telomere length, helping with agingAccording to researchers, their findings suggest that psilocybin assists with slowing aging by reducing oxidative stress, improving DNA repair responses, and maintaining the length of telomeres. Telomeres are the 'end caps' of chromosomes. By helping to preserve telomere lengths, the researchers believe this may help protect the body from age-related diseases like heart disease, neurodegeneration, and cancer. 'Psilocybin appears to reduce the 'wear and tear' that accompanies aging. Although psilocybin is well-known for its psychedelic effects, our study suggests that psilocybin has potent impacts on the entire body. Psilocybin holds great potential for promoting healthy aging — this is just the starting point, as much more research is needed.'— Louise Hecker, PhD'We need to better understand its mechanisms of action, in particular how it works outside the brain to impact systemic aging and other processes,' Hecker said. 'More research is needed to optimize dosing/frequency protocols as well as monitor for the potential of adverse effects before it is ready to be used clinically as an anti-aging agent.'More studies needed to translate findings to humansMNT spoke with Jack Jacoub, MD, a board certified medical oncologist and medical director of MemorialCare Cancer Institute at Orange Coast and Saddleback Medical Centers in Orange County, CA, about this study. 'Cell aging is a key feature to overall health and illnesses and cancer,' Jacoub said. 'And so there's a lot of therapies now that are looking at things like senescence, which is normal cell aging, how to slow it down, and how to repair the damage that happens with aging. Sometimes issues related to cancer are due to the inability to repair damage, and it becomes a cancerous cell.' Jacoub commented that while this was a very interesting and notable observational study, it's a big leap right now to say these findings will translate to human illnesses, including cancer. 'It's too general right now to say anti-aging — that's an incredible umbrella. For it to really make an impact, and for you to see it available and recommended, it's going to need to be advanced further, obviously in humans, but then in particular areas to be able to say, yes, there really is merit to this, we should be recommending this to patients, etc.' — Jack Jacoub, MD'Like for example, could it help repair injury quickly?,' Jacoub continued. 'That would be (an) interesting thing to observe and study. And so let's say it's stroke patients, heart attack patients, whatever it might be — is there some role there to use it and accelerate healing from events like that? (And) a good one would be cellular repair. Can you recover and heal faster if you took this? That would be an example of it.'
Daily Mail
2 hours ago
- Daily Mail
Alarming 763% spike in poisonings linked to popular new nicotine product
Poisonings linked to nicotine pouches have skyrocketed across the US, especially among young children, a new study has found. Researchers in Ohio found a 763 percent spike in poisonings among children under six years old from 2020 to 2023. The findings are particularly alarming given that the overall number of nicotine-related poisonings declined by 34 percent over the last eight years. Out of more than 134,000 cases of pediatric nicotine poisoning, researchers found that children exposed to nicotine pouches were twice as likely to be hospitalized and 50 percent more likely to suffer serious medical outcomes, including seizures. Nicotine pouches, small, typically white packets placed between the gum and upper lip, have gained popularity since they hit the US market in 2014. Each pouch contains between two and 12 milligrams of nicotine, making them the second most popular nicotine product among young adults. Just one to two milligrams of nicotine can poison a child, who is more at risk because of their small size, leading to sweating, pale skin and vomiting. In serious cases, it can cause tremors, seizures and even death. Researchers noted that while many nicotine products have become less common in the home, nicotine pouches appear to be bucking the trend, with more cases involving children gaining access to them, often mistaking them for candy or chewing gum. Dr Hannah Hays, an emergency medicine physician who led the study, warned: 'Nicotine pouches are a serious and growing toxic ingestion hazard among young children. 'The rapid increase in the number and comparative severity of nicotine pouch ingestions is a reminder of the public health challenges of the changing nicotine product market. 'This is why we need to continue ongoing surveillance and increase our efforts to prevent nicotine ingestions among young children.' For the study, published in the journal Pediatrics, researchers extracted data on nicotine poisonings from the National Poison Data System, a data warehouse from America's Poison Centers. Scientists analyzed cases among children under six years old that occurred between 2010 and 2023, and that involved any one of five products: nicotine tablets, gums/lozenges, liquids, powder and pouches. While nicotine pouches accounted for the fewest poisonings overall, just 1,800 cases, they were the only product to show a significant rise in poisonings in recent years, raising concern among researchers. The data revealed that two-thirds of the children poisoned by nicotine pouches were under the age of two, and nearly all exposures occurred at home, suggesting increased availability and accessibility of these products in domestic settings. The findings underscore the need for greater public awareness and preventive measures, as well as stricter packaging and storage requirements, to protect young children from accidental ingestion. The above graph shows how the rate of poisonings linked to nicotine pouches (purple line) has surged in recent years compared to the others Around 36 children experienced serious medical problems like seizures or breathing difficulties, but no deaths were reported. Dr Natalie Rine, a toxicologist and director of the Central Ohio Poisoning Center, who was a co-author of the study, told CNN: 'It's a high-concentration nicotine product, and it tastes good. 'There's nothing telling the kid, "This is bad, you should spit it out", and that's where you get into trouble.' Among cases where the source was known, e-liquids or e-cigarette fluids caused the most poisonings, with 33,000 cases. Tablets caused 23,000, powder 11,000, and gums or lozenges 8,000 cases. They were followed by tablets, at 23,000 cases, powder at 11,000 cases and gums/lozenges at 8,000 cases. Overall, 36 percent of ingestions had no effect, and 81.3 percent of cases did not require healthcare treatment. Thirty-nine children suffered major effects, including seizures, and two died after consuming e-liquid. Nicotine poisonings increased by 59 percent in the first five years of the study, then declined by 34 percent over the following eight years. There are no named cases of a baby being poisoned by a nicotine pouch. Philip Morris International, which owns the nicotine pouch brand Zyn through its company Swedish Match, said in a statement that the number of poisonings from pouches remains low. 'ZYN is the only nicotine pouch authorized by the FDA as appropriate to protect public health,' a spokesman said, 'In making that conclusion, the agency noted that ZYN's packaging is designed to be child resistant'. 'We welcome the chance to meet with these researchers and educate them on the robust actions Swedish Match takes to guard against underage use.'
